Ischemic cardiovascular complications concurrent with administration of captopril. A clinical note.
- 1 January 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 2 (1) , 73-74
- https://doi.org/10.1161/01.hyp.2.1.73
Abstract
Administration of potent vasodepressor agents such as the angiotensin converting enzyme inhibitor, captopril, may precipitate myocardial ischemic events in patients with coronary artery disease, particularly if this treatment is preceded by a discontinuation of beta-blocking drugs such as propranolol. In one case studied, a patient experienced three episodes of angina pectoris under these conditions; in another, acute anterior myocardial infarction was suspect.This publication has 5 references indexed in Scilit:
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Propranolol rebound—A retrospective studyThe American Journal of Cardiology, 1978
- Propranolol-Withdrawal Rebound PhenomenonNew England Journal of Medicine, 1975
- Adrenal Medullary Stimulation Induced by Angiotensin I, Angiotensin II, and AnaloguesCirculation Research, 1971